Correction: Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection

by Sulav Duwal, Christof Schütte, Max von Kleist
Published 2012-01-01

Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection.

by Sulav Duwal, Christof Schütte, Max von Kleist
Published 2012-01-01

Correction: Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection.

by Sulav Duwal, Christof Schütte, Max von Kleist
Published 2012-01-01

Optimal Treatment Strategies in the Context of 'Treatment for Prevention' against HIV-1 in Resource-Poor Settings.

by Sulav Duwal, Stefanie Winkelmann, Christof Schütte, Max von Kleist
Published 2015-04-01

Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis.

by Sulav Duwal, Laura Dickinson, Saye Khoo, Max von Kleist
Published 2019-01-01

Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes.

by Sulav Duwal, Laura Dickinson, Saye Khoo, Max von Kleist
Published 2018-06-01

The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis

by Sulav Duwal, Daniel Seeler, Laura Dickinson, Saye Khoo, Max von Kleist
Published 2019-03-01